Abstract
To review the clinical course and identify prognostic factors, we retrospectively analyzed 92 children with steroid-resistant primary focal segmental glomerulosclerosis (FSGS). The mean age of onset was 80.4±42.4 months. The mean follow-up duration was 98.2±63.3 months. Eighty-five patients presented with nephrotic syndrome and seven presented with asymptomatic proteinuria. Thirty-three patients were initial responders to steroid treatment (late non-responders) and 59 were initial nonresponders. At last follow-up, 36 patients (39.1%) were in complete remission, and 29 (31.5%) progressed to chronic renal failure (CRF). Renal survival rates at 5, 10, and 15 years were 84, 64, and 53%, respectively. By morphological classification, there were tip variants (6.1%), collapsing variants (10.6%), cellular variants (1.5%), perihilar variants (9.1%), and NOS (not otherwise specified, 72.7%). Among the variants, there were no significant differences in age of onset, degree of proteinuria, response to treatment, or progression to CRF. Poor prognostic factors for CRF included: asymptomatic proteinuria at presentation, initial renal insufficiency, higher segmental sclerosis (%), severe tubulointerstitial change, initial nonresponse, and absence of remission. In the multivariate analysis, an increase in the initial serum creatinine and resistance to treatment were independent risk factors for CRF. A more prolonged use of corticosteroid therapy and early introduction of cyclosporin A (CsA) may improve the prognosis for primary FSGS in patients with initial steroid nonresponsiveness.
Similar content being viewed by others
References
White RH, Glasgow EF, Mills RJ (1970) Clinicopathological study of nephrotic syndrome in childhood. Lancet 1:1353–1359
Habib R, Kleinknecht C (1971) The primary nephrotic syndrome of childhood. Classification and clinicopathologic study of 406 cases. Pathol Annu 6:417–474
(1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 98:561–564
Cattran DC, Rao P (1998) Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 32:72–79
Korbet SM (1999) Clinical picture and outcome of primary focal segmental glomerulosclerosis. Nephrol Dial Transplant 14(Suppl 3):68–73
Srivastava T, Simon SD, Alon US (1999) High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood. Pediatr Nephrol 13:13–18
Newman WJ, Tisher CC, McCoy RC, Gunnells JC, Krueger RP, Clapp JR, Robinson RR (1976) Focal glomerular sclerosis: contrasting clinical patterns in children and adults. Medicine (Baltimore) 55:67–87
Mongeau JG, Corneille L, Robitaille P, O’Regan S, Pelletier M (1981) Primary nephrosis in childhood associated with focal glomerular sclerosis: is long-term prognosis that severe? Kidney Int 20:743–746
(1985) Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group. Kidney Int 27:442–449
Pei Y, Cattran D, Delmore T, Katz A, Lang A, Rance P (1987) Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study. Am J Med 82:938–944
Korbet SM, Schwartz MM, Lewis EJ (1994) Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis 23:773–783
Beaufils H, Alphonse JC, Guedon J, Legrain M (1978) Focal glomerulosclerosis: natural history and treatment. A report of 70 cases. Nephron 21:75–85
Tejani A, Nicastri AD, Sen D, Chen CK, Phadke K, Adamson O, Butt KM (1983) Long-term evaluation of children with nephrotic syndrome and focal segmental glomerular sclerosis. Nephron 35:225–231
Ingulli E, Tejani A (1991) Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 5:393–397
Mongeau JG, Robitaille PO, Clermont MJ, Merouani A, Russo P (1993) Focal segmental glomerulosclerosis (FSG) 20 years later. From toddler to grown up. Clin Nephrol 40:1–6
Cameron JS (1996) The enigma of focal segmental glomerulosclerosis. Kidney Int(Suppl 57):S119–S131
D’Agati VD, Fogo AB, Bruijn JA, Jennette JC (2004) Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 43:368–382
Schwartz GJ, Haycock GB, Edelmann CM, Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263
Burritt MF, Slockbower JM, Forsman RW, Offord KP, Bergstralh EJ, Smithson WA (1990) Pediatric reference intervals for 19 biologic variables in healthy children. Mayo Clin Proc 65:329–336
Cherian AG, Hill JG (1978) Percentile estimates of reference values for fourteen chemical constituents in sera of children and adolescents. Am J Clin Pathol 69:24–31
Mendoza SA, Reznik VM, Griswold WR, Krensky AM, Yorgin PD, Tune BM (1990) Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol 4:303–307
Sorof JM, Hawkins EP, Brewer ED, Boydstun, II, Kale AS, Powell DR (1998) Age and ethnicity affect the risk and outcome of focal segmental glomerulosclerosis. Pediatr Nephrol 12:764–768
Ellis D, Kapur S, Antonovych TT, Salcedo JR, Yunis EJ (1978) Focal glomerulosclerosis in children: correlation of histology with prognosis. J Pediatr 93:762–768
Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG (1978) The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10:213–218
Arbus GS, Poucell S, Bacheyie GS, Baumal R (1982) Focal segmental glomerulosclerosis with idiopathic nephrotic syndrome: three types of clinical response. J Pediatr 101:40–45
Yoshikawa N, Ito H, Akamatsu R, Matsuyama S, Hasegawa O, Nakahara C, Matsuo T (1986) Focal segmental glomerulosclerosis with and without nephrotic syndrome in children. J Pediatr 109:65–70
Tufro-McReddie A, Alvarez E, Arrizurieta E, Repetto H (1992) Focal glomerulosclerosis in children: an Argentinian experience. Pediatr Nephrol 6:158–161
Martinelli R, Okumura AS, Pereira LJ, Rocha H (2001) Primary focal segmental glomerulosclerosis in children: prognostic factors. Pediatr Nephrol 16:658–661
Abrantes MM, Cardoso LS, Lima EM, Silva JM, Diniz JS, Bambirra EA, Oliveira EA (2006) Clinical course of 110 children and adolescents with primary focal segmental glomerulosclerosis. Pediatr Nephrol 21:482–489
Korbet SM, Schwartz MM, Lewis EJ (1986) The prognosis of focal segmental glomerular sclerosis of adulthood. Medicine (Baltimore) 65:304–311
Detwiler RK, Falk RJ, Hogan SL, Jennette JC (1994) Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45:1416–1424
Valeri A, Barisoni L, Appel GB, Seigle R, D’Agati V (1996) Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study. Kidney Int 50:1734–1746
Schwartz MM (2005) The blind men and the elephant. Kidney Int 68:1894–1895
Saint-Hillier Y, Morel-Maroger L, Woodrow D, Richet G (1975) Focal and segmental hyalinosis. Adv Nephrol Necker Hosp 5:67–88
Velosa JA, Holley KE, Torres VE, Offord KP (1983) Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis. Mayo Clin Proc 58:568–577
McAdams AJ, Valentini RP, Welch TR (1997) The nonspecificity of focal segmental glomerulosclerosis. The defining characteristics of primary focal glomerulosclerosis, mesangial proliferation, and minimal change. Medicine (Baltimore) 76:42–52
Habib R, Gubler MC (1973) Focal sclerosing glomerulonephritis. Perspect Nephrol Hypertens 1 Pt 1:263–278
Chan PC, Chan KW, Cheng IK, Chan MK (1991) Focal sclerosing glomerulopathy. Risk factors of progression and optimal mode of treatment. Int Urol Nephrol 23:619–629
Banfi G, Moriggi M, Sabadini E, Fellin G, D’Amico G, Ponticelli C (1991) The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol 36:53–59
Miyata J, Takebayashi S, Taguchi T, Naito S, Harada T (1986) Evaluation and correlation of clinical and histological features of focal segmental glomerulosclerosis. Nephron 44:115–120
Guillot AP, Kim MS (1993) Pulse steroid therapy does not alter the course of focal segmental glomerulosclerosis (abstract). J Am Soc Nephrol 4:276
Waldo FB, Benfield MR, Kohaut EC (1992) Methylprednisolone treatment of patients with steroid-resistant nephrotic syndrome. Pediatr Nephrol 6:503–505
Hari P, Bagga A, Jindal N, Srivastava RN (2001) Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide. Pediatr Nephrol 16:901–905
Alexopoulos E, Stangou M, Papagianni A, Pantzaki A, Papadimitriou M (2000) Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis. Nephrol Dial Transplant 15:1348–1356
Passerini P, Ponticelli C (2001) Treatment of focal segmental glomerulosclerosis. Curr Opin Nephrol Hypertens 10:189–193
Korbet SM (1998) Primary focal segmental glomerulosclerosis. J Am Soc Nephrol 9:1333–1340
Ponticelli C (1995) Focal segmental glomerular sclerosis. To treat or not to treat? 1. It is worthwhile to give the adult patient with nephrotic syndrome the benefit of an adequate therapeutic trial? Nephrol Dial Transplant 10:2351–2354
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Paik, K.H., Lee, B.H., Cho, H.Y. et al. Primary focal segmental glomerular sclerosis in children: clinical course and prognosis. Pediatr Nephrol 22, 389–395 (2007). https://doi.org/10.1007/s00467-006-0301-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-006-0301-5